Reviews
21 February 2025
Early Access
https://doi.org/10.4081/dr.2025.10166

The efficacy and safety of micro-needling combined with tacrolimus versus tacrolimus monotherapy for vitiligo treatment: a systematic review and meta-analysis

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Vitiligo, micro-needling, tacrolimus, 5-grade re-pigmentation scale, Physician's Global Assessment, histopathological assessment
280
Views
193
Downloads

Authors

Hadeel A. Maaddawi
Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Abdulaziz A. Aljuaid
Abdulaziz.aljuaid@outlook.com
College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Awadh M. Alamri
https://orcid.org/0009-0008-9874-9322
King Abdullah International Medical Research Center, Jeddah; Department of Dermatology, King Abdulaziz Medical City, Jeddah; Assistant professor, College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Dhaifallah H. Alghowairi
Dermatology consultant, Ministry of Defence, Riyadh, Saudi Arabia.
Abdullah S. Bawazeer
Histopathology consultant, Ministry of Defence, Riyadh, Saudi Arabia.

Tacrolimus is a topical immunomodulator that has been used successfully in treating vitiligo; however, recent studies suggested that combining tacrolimus with micro-needling can increase its efficacy. This systematic review aimed to assess the efficacy and safety of micro-needling combined with tacrolimus to treat localized and stable nonsegmental vitiligo. We searched Medline, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL). The risk ratio (RR) was used to represent dichotomous outcomes, whereas the odds ratio (OR) was used for adverse events. Three randomized control trials (RCTs) (n=148 participants) were deemed eligible. The pooled effect estimate showed a statistically significant higher re-pigmentation rate in all assessed body areas in favor of treatment with micro-needling combined with tacrolimus (RR=2.02, 95% CI: 1.51-2.70). Nonetheless, no significant difference was found between micro-needling combined with tacrolimus and tacrolimus monotherapy in terms of 5-grade re-pigmentation scale (RR=0.93, 95% CI: 0.53-1.62), histopathological assessment (RR=0.90, 95% CI 0.47-1.75), and adverse events (OR: 1.72, 95% CI: 0.10-29.36). The number of included studies is low, with a relatively low sample size. Micro-needling combined with tacrolimus showed a clinically and statistically substantial improvement in the re-pigmentation of vitiligo sites with acceptable tolerability and safety profile.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Faria AR, Tarlé RG, Dellatorre G, et al. Vitiligo--Part 2--classification, histopathology and treatment. An Bras Dermatol 2014;89:784-90. DOI: https://doi.org/10.1590/abd1806-4841.20142717
Bergqvist C, Ezzedine K. Vitiligo: A Review. Dermatology 2020;236:571-92. DOI: https://doi.org/10.1159/000506103
Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet 2015;386:74-84. DOI: https://doi.org/10.1016/S0140-6736(14)60763-7
Krüger C, Schallreuter KU. Stigmatisation, Avoidance Behaviour and Difficulties in Coping are Common Among Adult Patients with Vitiligo. Acta Derm Venereol 2015;95:553-8. DOI: https://doi.org/10.2340/00015555-1981
Felsten LM, Alikhan A, Petronic-Rosic V. Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment. J Am Acad Dermatol 2011;65:493-514. DOI: https://doi.org/10.1016/j.jaad.2010.10.043
Anbar TS, Hegazy RA, Picardo M, Taieb A. Beyond vitiligo guidelines: combined stratified/personalized approaches for the vitiligo patient. Exp Dermatol 2014;23:219-23. DOI: https://doi.org/10.1111/exd.12344
Abd-Elazim NE, Yassa HA, Mahran AM. Microdermabrasion and topical tacrolimus: A novel combination therapy of vitiligo. J Cosmet Dermatol 2020;19:1447-55. DOI: https://doi.org/10.1111/jocd.13193
Ebrahim HM, Albalate W. Efficacy of microneedling combined with tacrolimus versus either one alone for vitiligo treatment. J Cosmet Dermatol 2020;19:855-62. DOI: https://doi.org/10.1111/jocd.13304
Ebrahim HM, Elkot R, Albalate W. Combined microneedling with tacrolimus vs tacrolimus monotherapy for vitiligo treatment. J Dermatol Treat 2021;32,999–1004. DOI: https://doi.org/10.1080/09546634.2020.1716930
Esmat SM, Gawdat HI, Hegazy RA, et al. Different methods of enhancing the efficacy of topical tacrolimus in extra-facial vitiligo: A comparative study. J Cosmet Dermatol 2021;20:3545-51. DOI: https://doi.org/10.1111/jocd.14024
Sharma1 S. Evaluation of combination of microneedling with tacrolimus in the Treatment of Stable Vitiligo. Port J Dermatol 2021;79. DOI: https://doi.org/10.29021/spdv.79.3.1336
Joseph-Michel Bailey A, Oi-Yee Li H, Zheng D, et al. Microneedling as an Adjuvant to Local Therapies for Vitiligo: A Systematic Review and Meta-Analysis. Dermatol Surg 2021;47:1314-6. DOI: https://doi.org/10.1097/DSS.0000000000003048
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009;62:e1-34. DOI: https://doi.org/10.1016/j.jclinepi.2009.06.006
Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898. DOI: https://doi.org/10.1136/bmj.l4898
Korobko IV, Lomonosov KM. A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo. Dermatol Ther 2016;29:437-41. DOI: https://doi.org/10.1111/dth.12383
Mina M, Elgarhy L, Al-Saeid H, Ibrahim Z. Comparison between the efficacy of microneedling combined with 5-fluorouracil vs microneedling with tacrolimus in the treatment of vitiligo. J Cosmet Dermatol 2018;17:744-51. DOI: https://doi.org/10.1111/jocd.12440
Ibrahim ZA, Hassan GF, Elgendy HY, Al-Shenawy HA. Evaluation of the efficacy of transdermal drug delivery of calcipotriol plus betamethasone versus tacrolimus in the treatment of vitiligo. J Cosmet Dermatol 2019;18:581-8. DOI: https://doi.org/10.1111/jocd.12704
Fai D, Cassano N, Vena GA. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients. J Eur Acad Dermatol Venereol 2007;21:916-20. DOI: https://doi.org/10.1111/j.1468-3083.2006.02101.x
Nordal EJ, Guleng GE, Rönnevig JR. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study. J Eur Acad Dermatol Venereol 2011;25:1440-3. DOI: https://doi.org/10.1111/j.1468-3083.2011.04002.x
Bilal A, Shiakh ZI, Khan S, et al. Efficacy of 0.1% topical tacrolimus with narrow band ultraviolet B phototherapy versus narrow band ultraviolet B phototherapy in vitiligo. J Pak Assoc Dermatol 2016;24:327-31.
Attwa EM, Khashaba SA, Ezzat NA. Evaluation of the additional effect of topical 5-fluorouracil to needling in the treatment of localized vitiligo. J Cosmet Dermatol 2020;19:1473-8. DOI: https://doi.org/10.1111/jocd.13152
Ju HJ, Bae JM, Lee RW, et al. Surgical Interventions for Patients With Vitiligo: A Systematic Review and Meta-analysis. JAMA Dermatol 2021;157:307-16. DOI: https://doi.org/10.1001/jamadermatol.2020.5756
Cohen BE, Elbuluk N. Microneedling in skin of color: A review of uses and efficacy. J Am Acad Dermatol 2016;74:348-55. DOI: https://doi.org/10.1016/j.jaad.2015.09.024

How to Cite



The efficacy and safety of micro-needling combined with tacrolimus versus tacrolimus monotherapy for vitiligo treatment: a systematic review and meta-analysis. (2025). Dermatology Reports. https://doi.org/10.4081/dr.2025.10166
Copyright (c) 2025 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.